Indicators

Latest News about RHHBY

Recent news which mentions RHHBY

...

10 11 12 13 14 15 16 17 Next >

Recession Fears are Creating a Golden Opportunity for Biotech Stocks

April 08, 2022

SoftBank Loses Vision Fund Leader; Continues To Liquidate Portfolio

April 04, 2022

Genentech's Ocrevus Shows Benefit In Disability Progression & Cognitive Decline In Multiple Sclerosis

April 04, 2022

FDA Grants Priority Review To Roche's Actemra For Hospitalized COVID-19 Adults

April 04, 2022

Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates

April 01, 2022

Roche's Tiragolumab Immunotherapy Flunks In Late-Stage Lung Cancer Trial

March 30, 2022

The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict

March 30, 2022

Drug makers, Scientists Working For Long COVID Treatments: Reuters

March 25, 2022

The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO

March 25, 2022

Why Are ImmunoGen Shares Trading Lower Today

March 21, 2022

Roche's Evrysdi Shows Long-Term Efficacy, Safety In Broader Spinal Muscular Atrophy Population

March 16, 2022

2 Top Stocks to Buy in March and Hold Forever

March 15, 2022

The OTCQX's Top 10 Experience A Shuffle In February

March 15, 2022

The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial

March 15, 2022

Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy

March 15, 2022

Biogen Posts New Updates Across its Spinraza SMA Research Program

March 14, 2022

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings

March 13, 2022

OTC Markets 2021 Annual Data Review Highlights A Record 60% $ Volume Increase

March 07, 2022

Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off.

March 04, 2022

Viatris Just Snagged a Major FDA Approval

March 03, 2022

2 Biotech Stocks That Could Make You Richer

March 02, 2022

Roche And AstraZeneca Settle Ultomiris Patent Lawsuit

February 22, 2022

Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial

February 18, 2022

3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch

February 16, 2022

These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators

February 14, 2022

Why Are Seagen Shares Sinking Today?

February 10, 2022

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More

February 06, 2022

Cathie Wood's Ark Invest Sheds Stake In This Large-Cap Pharma Ahead Of Earnings

February 05, 2022

The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation

February 03, 2022

Roche Expects Slower FY22 Sales Growth On Lower Demand For COVID-19 Tests

February 03, 2022

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.